← All drugs Report issue

chimeric antigen receptor t cell o&d-001 injection targeting bcma and gprc5d

Cell therapyexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

G-protein coupled receptor family C group 5 member DImmunity, passive
GPRC5D immunity, passive
- G-protein coupled receptor family C group 5 member D (GPRC5D) ↗
BCMAImmunity, passive
BCMA immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No